OpGen, Inc.
http://opgen.com/
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From OpGen, Inc.
Molecular Diagnostic Firms Curetis And OpGen Announce Merger
The combination of the molecular diagnostic companies is structured as an acquisition of Curetis by OpGen. The merged companies will be a based in the US.
Deals Shaping the Medical Industry, August 2017
Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced July 2017.
Rapid Infectious Disease Testing Picks Up Speed
Recent regulatory events and dealmaking highlight an increase in the pace of innovation in rapid infectious disease testing.
Medtech Execs On The Move, June 2016
Recent executive-level company changes and promotions in the medical device and diagnostics industries.
Company Information
- Industry
- Research, Analytical Equipment & Supplies
- Services
-
In Vitro Diagnostics
- Molecular Diagnostics & Genetic Testing
-
Biotechnology
-
Drug Discovery Tools
- Bioinformatics
-
Drug Discovery Tools
- Other Names / Subsidiaries
-
- AdvanDx, Inc.
- AdvanDx A/S, Curetis N.V.
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice